Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
WARNER CHILCOTT LABORATORIES IRELAND LIMITED et al v. MYLAN PHARMACEUTICALS INC. et al
Case Number:
2:09-cv-02073
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
February 08, 2012
Mylan Can't Launch Doryx Generic Just Yet
A New Jersey federal judge on Wednesday blocked Mylan Pharmaceuticals Inc. from launching a generic version of Warner Chilcott PLC's anti-acne medication Doryx.
-
September 22, 2011
Judge Bars Mylan's Generic Doryx For Now
A New Jersey federal judge on Thursday blocked generic-drug maker Mylan Inc. from introducing its own version of the oral antibiotic Doryx until a court rules on patent infringement allegations brought by Warner Chilcott Ltd. in 2009.